Home > Resources > Whitepapers > International Research Journal of Engineering and Technology

International Research Journal of Engineering and Technology

January 1, 2017

At present cloud computing is a very famous technology in IT enterprises. For a company, the data stored is extremely very large and it is very adored. Thus, it becomes very important to have the secured use of data. For this most prior option is a private cloud using which we can keep the data more securely than other. In this paper I am going to discuss about how we can access a private cloud and its uses.

Spotlight

Cambridge Epigenetix

Cambridge Epigenetix Ltd is commercializing a novel technology that pioneers quantitative single-base resolution sequencing of the methylated bases 5-hmC and 5-mC leading to substantially more accurate determination of the methylated status of genomic DNA with relevance in research, pharmaceutical discovery and diagnostics.

OTHER WHITEPAPERS

Bioanalytical Techniques to Advance Biosimilars Development

whitePaper | August 22, 2022

Biosimilar therapies offer more unique approaches to treating patients with serious diseases, such as cancer.

Imaweld® heat sealable & weldable tube bioprocess media

whitePaper | February 3, 2023

Imaweld® is thermoplastic elastomer tubing particularly designed to transfer critical fluid in pharmaceutical and biopharmaceutical applications.

Innovative strategies to maintain product integrity in Biologic andBiosimilar clinical studies

whitePaper | August 7, 2022

The number of biologic new molecular entities approved by the FDA has increased over the last five years indicates a growing focus on biosimilar.

Internal Co-ordination Group for Biotechnology

whitePaper | October 19, 2022

The Organisation for Economic Co-operation and Development and its member countries have been addressing issues related to biotechnology since 1982.

Recruitment, Retention & Diversity: The Evolution of Patient Engagement in Clinical Trials

whitePaper | January 23, 2023

Recruitment, retention, and diversity are critical elements of clinical trials that, if insufficient, can jeopardize successful trial completion.

Connecting materials sciences with fungal biology: a sea of possibilities

whitePaper | March 1, 2022

The Special Issue “Connecting materials science with fungal biology” celebrates recent breakthroughs in the fabrication of fungal-based materials, all of which have been made possible by the interdisciplinary and transdisciplinary collaboration of fungal biologists and biotechnologists with artists, designers, materials scientists, and architects